Approval · Notice of Compliance 3504 · 2003
FASTURTEC: Notice of Compliance 3504
Issued October 29, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3504
- Date
- October 29, 2003
- Company
- Sanofi-Synthelabo Canada Inc.Laval, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Uricolytic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FASTURTEC | 02248416 | Marketed |
Medicinal ingredients
- RASBURICASE 1.5 MG per VIAL